Jolt Capital, an independent private equity firm specialising in growth investments in European deeptech companies, is to make a €24m investment in BioSerenity, a specialist in connected medical devices and innovative medical services in electrophysiology.
Founded in 2014, BioSerenity has designed a range of medical devices and software for electroencephalography. The company has also extended the scope of its solutions to other fields, including sleep disorders. Today, with more than 300 partners and 150,000 patients treated each year, BioSerenity is a leader in neurological diagnostics and sleep disorders.
Jolt Capital’s investment of €24m will enable the company to accelerate the international development of its activities by building on its two main markets, France and the United States, and focusing on Europe. The funding will also be used to deploy even more powerful artificial intelligence to help doctors with their diagnoses. Finally, the company’s management team will be strengthened to drive BioSerenity’s development.
